Meyer Andrew Hollman

Insider profile

Performance

Overall performance
1.8

Performance over holding periods
1.8
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Meyer Andrew Hollman's trades of Janux Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-13 2026-04-13 PrS Proposed sale
55,389
346.77
US$2,620,952
55,389 346.77 US$2,620,952
2026-01-26 2026-01-26 PrS Proposed sale
38,619
340.66
US$4,682,186
38,619 340.66 US$4,682,186
2026-01-23 2026-01-23 PrS Proposed sale
36,017
275.52
US$4,544,499
36,017 275.52 US$4,544,499
2026-01-02 2026-01-02 S Sale
1,879 -2.2%
13.73
US$25,799
1,879 -2.2% 13.73 US$25,799
2025-12-03 2025-12-01 PlS Planned sale
633 -0.7%
33.52
US$21,221
633 -0.7% 33.52 US$21,221
2025-12-03 2025-12-01 PlS Planned sale
2,700 -3.1%
32.85
US$88,708
2,700 -3.1% 32.85 US$88,708
2025-12-01 2025-12-01 PrS Proposed sale
3,333
34.09
US$113,622
3,333 34.09 US$113,622
2025-11-14 2025-11-14 PrS Proposed sale
3,333
27.46
US$91,524
3,333 27.46 US$91,524
2025-11-14 2025-11-14 PlS Planned sale
3,333 -3.8%
30.00
US$99,990
3,333 -3.8% 30.00 US$99,990
2025-10-30 2025-10-28 PlS Planned sale
16,665 -16.9%
30.06
US$500,987
16,665 -16.9% 30.06 US$500,987
2025-10-28 2025-10-28 PrS Proposed sale
16,665
27.35
US$455,788
16,665 27.35 US$455,788
2025-05-02 2025-05-01 PlS Planned sale
400 -0.5%
32.60
US$13,041
400 -0.5% 32.60 US$13,041
2025-05-02 2025-05-01 PlS Planned sale
2,933 -3.4%
31.95
US$93,703
2,933 -3.4% 31.95 US$93,703
2025-05-01 2025-05-01 PrS Proposed sale
3,333
33.20
US$110,656
3,333 33.20 US$110,656
2025-04-23 2025-04-21 PlS Planned sale
3,334 -3.9%
30.00
US$100,020
3,334 -3.9% 30.00 US$100,020
2025-04-21 2025-04-21 PrS Proposed sale
3,334
29.69
US$98,986
3,334 29.69 US$98,986
2025-03-05 2025-03-03 PlS Planned sale
901 -1.1%
32.85
US$29,599
901 -1.1% 32.85 US$29,599
2025-03-05 2025-03-03 PlS Planned sale
2,433 -2.8%
31.88
US$77,576
2,433 -2.8% 31.88 US$77,576
2025-03-03 2025-03-03 PrS Proposed sale
3,334
32.89
US$109,655
3,334 32.89 US$109,655
2025-02-05 2025-02-03 PlS Planned sale
100 -0.1%
43.60
US$4,360
100 -0.1% 43.60 US$4,360
2025-02-05 2025-02-03 PlS Planned sale
816 -1.0%
42.77
US$34,901
816 -1.0% 42.77 US$34,901
2025-02-05 2025-02-03 PlS Planned sale
2,418 -2.8%
42.08
US$101,739
2,418 -2.8% 42.08 US$101,739
2025-02-03 2025-02-03 PrS Proposed sale
3,334
43.48
US$144,962
3,334 43.48 US$144,962
2025-01-03 2025-01-02 PlS Planned sale
200 -0.2%
57.37
US$11,473
200 -0.2% 57.37 US$11,473
2025-01-03 2025-01-02 PlS Planned sale
1,000 -1.2%
56.78
US$56,778
1,000 -1.2% 56.78 US$56,778
2025-01-03 2025-01-02 PlS Planned sale
3,444 -4.0%
55.76
US$192,033
3,444 -4.0% 55.76 US$192,033
2025-01-03 2025-01-02 PlS Planned sale
5,768 -6.2%
54.51
US$314,420
5,768 -6.2% 54.51 US$314,420
2025-01-03 2025-01-02 PlS Planned sale
2,922 -3.1%
53.76
US$157,081
2,922 -3.1% 53.76 US$157,081
2025-01-02 2025-01-02 PrS Proposed sale
13,334
53.54
US$713,902
13,334 53.54 US$713,902
2024-09-27 2024-09-27 PrS Proposed sale
50,000
45.96
US$2,297,755
50,000 45.96 US$2,297,755
2024-09-27 2024-09-27 S Sale
50,000 -42.5%
45.96
US$2,297,755
50,000 -42.5% 45.96 US$2,297,755